Detalhe da pesquisa
1.
High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients.
Cell
; 186(12): 2705-2718.e17, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37295406
2.
A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract.
Blood
; 141(12): 1389-1401, 2023 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399701
3.
Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease.
Blood
; 140(22): 2385-2397, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35969834
4.
Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant.
Blood
; 139(18): 2758-2769, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35061893
5.
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.
N Engl J Med
; 382(9): 822-834, 2020 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32101664
6.
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study.
Blood
; 137(11): 1527-1537, 2021 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512409
7.
A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation.
Cancer
; 128(21): 3850-3859, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041227
8.
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD.
Blood
; 136(1): 130-136, 2020 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32430495
9.
Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease.
Nat Microbiol
; 9(3): 614-630, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429422
10.
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation.
Cancer Immunol Res
; 12(3): 308-321, 2024 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38108398
11.
Learning from the microbes: exploiting the microbiome to enforce T cell immunotherapy.
Front Immunol
; 14: 1269015, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37799719
12.
Circulating microbial cell-free DNA is increased during neutropenia after hematopoietic stem cell transplantation.
Blood Adv
; 7(21): 6744-6750, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37399491
13.
Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation.
Clin Cancer Res
; 29(1): 165-173, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36322005
14.
Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse.
Sci Transl Med
; 15(706): eabq0476, 2023 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494469
15.
Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma.
Transplant Cell Ther
; 28(11): 751.e1-751.e7, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944603
16.
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.
Nat Med
; 28(4): 713-723, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35288695
17.
MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT.
Sci Transl Med
; 14(646): eabj2829, 2022 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35613281
18.
Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition.
Blood Adv
; 3(13): 2040-2044, 2019 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289031
19.
Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.
Nat Med
; 29(11): 2954, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36253610
20.
Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.
J Clin Oncol
; 35(15): 1650-1659, 2017 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28296584